Resume
She received her post-doctoral training from the National Institute of Health, USA. Dr. Tiwari has received many research grants and awards during her research career, including the prestigious Ramalingaswami National Fellowship from the Department of Biotechnology, Government of India. Dr. Tiwari initiated translational research programs on biological nanovesicles at SGPGI with the vision to improve healthcare through the discovery of molecular predictors of diseases. Her research team is the first in India to establish and demonstrate the usefulness of the urinary exosome for predicting kidney injury. She has been awarded a Center of Advanced Research and Excellence (CARE) on Kidney disease- Biomarker and Newer therapeutics in 2019 by the Indian Council of Medical Research. Also, her laboratory's work provided the first unequivocal mechanism for the direct effect of insulin on nitric oxide production in the kidney and has demonstrated a significant role of the renal insulin receptor in whole-body glucose metabolism and hypertension. Dr. Tiwari has taken several initiatives to launch investigations to assess high-risk pregnancies and cervical cancer. In response to the COVID-19 pandemic, her laboratory has developed an RNA-based technology for rapid and affordable COVID-19 testing. At present, her laboratory is engaged in developing novel tools for monitoring placental and kidney health